ArticleCancer research2011

mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment.

Qun Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.